SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-125941
Filing Date
2020-11-17
Accepted
2020-11-16 17:32:52
Documents
17
Period of Report
2020-11-16
Items
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2036059d2_8k.htm   iXBRL 8-K 58727
2 EXHIBIT 3.1 tm2036059d2_ex3-1.htm EX-3.1 23884
3 EXHIBIT 3.2 tm2036059d2_ex3-2.htm EX-3.2 61632
4 EXHIBIT 4.1 tm2036059d2_ex4-1.htm EX-4.1 23583
5 EXHIBIT 4.2 tm2036059d2_ex4-2.htm EX-4.2 26017
9 GRAPHIC tm2036059d2_8kimg001.jpg GRAPHIC 3086
  Complete submission text file 0001104659-20-125941.txt   419283

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA amag-20201116.xsd EX-101.SCH 3192
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE amag-20201116_lab.xml EX-101.LAB 34591
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amag-20201116_pre.xml EX-101.PRE 22714
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2036059d2_8k_htm.xml XML 3498
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 6174983300
AMAG PHARMACEUTICALS, INC. (Filer) CIK: 0000792977 (see all company filings)

IRS No.: 042742593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10865 | Film No.: 201318598
SIC: 2834 Pharmaceutical Preparations